Healthcare -
Biotechnology - NASDAQ - GB
$ 10.72
-2.28 %
$ 740 M
Market Cap
-3.7
P/E
Price Target
Average
266.14%
Revenue Forecast
Estimate
138.09%
EBIT
Estimate
--24.22%
Net Income
Estimate
28.27%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bicycle Therapeutics plc
Wall Street analysts predict an average 1-year price target for BCYC of $39.2 , with forecasts ranging from
a
low of
$26 to a high of $55 .
BCYC Lowest Price Target
Wall Street Target
26 USD
142.54%
BCYC Average Price Target
Wall Street Target
39.2 USD
266.14%
BCYC Highest Price Target
Wall Street Target
55 USD
413.06%
REVENUE FORECAST
Revenue Forecast Chart BCYC
EBIT FORECAST
EBIT Forecast Chart BCYC
NET INCOME FORECAST
Net Income Chart BCYC